NameFlagsCard.TypeDescription & Constraintsdoco
.. MedicinalProductPharmaceutical ΣTUDomainResourceA pharmaceutical product described in terms of its composition and dose form
Elements defined in Ancestors: id, meta, implicitRules, language, text, contained, extension, modifierExtension
... identifier Σ0..*IdentifierAn identifier for the pharmaceutical medicinal product
... administrableDoseForm Σ1..1CodeableConceptThe administrable dose form, after necessary reconstitution
... unitOfPresentation Σ0..1CodeableConceptTodo
... ingredient Σ0..*Reference(MedicinalProductIngredient)Ingredient
... device Σ0..*Reference(MedicinalProductDeviceSpec | DeviceDefinition)Accompanying device
... characteristics Σ0..*BackboneElementCharacteristics e.g. a products onset of action
.... code Σ1..1CodeableConceptA coded characteristic
.... status Σ0..1CodeableConceptThe status of characteristic e.g. assigned or pending
... routeOfAdministration Σ1..*BackboneElementThe path by which the pharmaceutical product is taken into or makes contact with the body
.... code Σ1..1CodeableConceptCoded expression for the route
.... firstDose Σ0..1QuantityThe first dose (dose quantity) administered in humans can be specified, for a product under investigation, using a numerical value and its unit of measurement
.... maxSingleDose Σ0..1QuantityThe maximum single dose that can be administered as per the protocol of a clinical trial can be specified using a numerical value and its unit of measurement
.... maxDosePerDay Σ0..1QuantityThe maximum dose per day (maximum dose quantity to be administered in any one 24-h period) that can be administered as per the protocol referenced in the clinical trial authorisation
.... maxDosePerTreatmentPeriod Σ0..1RatioThe maximum dose per treatment period that can be administered as per the protocol referenced in the clinical trial authorisation
.... maxTreatmentPeriod Σ0..1DurationThe maximum treatment period during which an Investigational Medicinal Product can be administered as per the protocol referenced in the clinical trial authorisation
.... targetSpecies Σ0..*BackboneElementA species for which this route applies
..... code Σ1..1CodeableConceptCoded expression for the species
..... withdrawalPeriod Σ0..*BackboneElementA species specific time during which consumption of animal product is not appropriate
...... tissue Σ1..1CodeableConceptCoded expression for the type of tissue for which the withdrawal period applues, e.g. meat, milk
...... value Σ1..1QuantityA value for the time
...... supportingInformation Σ0..1stringExtra information about the withdrawal period

doco Documentation for this format